These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 33836690)

  • 21. Prognostic accuracy of cerebroplacental ratio for adverse perinatal outcomes in pregnancies complicated with severe pre-eclampsia; a prospective cohort study.
    Alanwar A; El Nour AA; El Mandooh M; Abdelazim IA; Abbas L; Abbas AM; Abdallah A; Nossair WS; Svetlana S
    Pregnancy Hypertens; 2018 Oct; 14():86-89. PubMed ID: 30527124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic accuracy of cerebroplacental ratio and middle cerebral artery Doppler for adverse perinatal outcome: systematic review and meta-analysis.
    Vollgraff Heidweiller-Schreurs CA; De Boer MA; Heymans MW; Schoonmade LJ; Bossuyt PMM; Mol BWJ; De Groot CJM; Bax CJ
    Ultrasound Obstet Gynecol; 2018 Mar; 51(3):313-322. PubMed ID: 28708272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does gestational age at term play a role in the association between cerebroplacental ratio and operative delivery for intrapartum fetal compromise?
    Ortiz JU; Graupner O; Karge A; Flechsenhar S; Haller B; Ostermayer E; Abel K; Kuschel B; Lobmaier SM
    Acta Obstet Gynecol Scand; 2021 Oct; 100(10):1910-1916. PubMed ID: 34212368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive accuracy of cerebroplacental ratio for adverse perinatal and neurodevelopmental outcomes in suspected fetal growth restriction: systematic review and meta-analysis.
    Conde-Agudelo A; Villar J; Kennedy SH; Papageorghiou AT
    Ultrasound Obstet Gynecol; 2018 Oct; 52(4):430-441. PubMed ID: 29920817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perinatal loss at term: role of uteroplacental and fetal Doppler assessment.
    Monaghan C; Binder J; Thilaganathan B; Morales-Roselló J; Khalil A
    Ultrasound Obstet Gynecol; 2018 Jul; 52(1):72-77. PubMed ID: 28436166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomised controlled trial comparing standard or intensive management of reduced fetal movements after 36 weeks gestation--a feasibility study.
    Heazell AE; Bernatavicius G; Roberts SA; Garrod A; Whitworth MK; Johnstone ED; Gillham JC; Lavender T
    BMC Pregnancy Childbirth; 2013 Apr; 13():95. PubMed ID: 23590451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study protocol for a randomized trial on timely delivery versus expectant management in late preterm small for gestational age pregnancies with an abnormal umbilicocerebral ratio (UCR): the DRIGITAT study.
    Smies M; Damhuis SE; Duijnhoven RG; Leemhuis AG; Gordijn SJ; Ganzevoort W
    Trials; 2022 Aug; 23(1):619. PubMed ID: 35915472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of cerebroplacental ratio.
    Kalafat E; Khalil A
    Curr Opin Obstet Gynecol; 2018 Dec; 30(6):344-354. PubMed ID: 30299319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in fetal Doppler indices as a marker of failure to reach growth potential at term.
    Morales-Roselló J; Khalil A; Morlando M; Papageorghiou A; Bhide A; Thilaganathan B
    Ultrasound Obstet Gynecol; 2014 Mar; 43(3):303-10. PubMed ID: 24488879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship between intrapartum cerebroplacental ratio and adverse perinatal outcomes in term fetuses.
    Chainarong N; Petpichetchian C
    Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():82-86. PubMed ID: 29909268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of abnormal cerebroplacental ratio in predicting adverse fetal outcome in pregnancies with scheduled induction of labor.
    Günay T; Bilir RA; Hocaoğlu M; Bör ED; Özdamar Ö; Turgut A
    Int J Gynaecol Obstet; 2021 May; 153(2):287-293. PubMed ID: 33159324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of poor perinatal outcome following maternal perception of reduced fetal movements--a prospective cohort study.
    Dutton PJ; Warrander LK; Roberts SA; Bernatavicius G; Byrd LM; Gaze D; Kroll J; Jones RL; Sibley CP; Frøen JF; Heazell AE
    PLoS One; 2012; 7(7):e39784. PubMed ID: 22808059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebroplacental ratio thresholds measured within 2 weeks before birth and risk of Cesarean section for intrapartum fetal compromise and adverse neonatal outcome.
    Bligh LN; Alsolai AA; Greer RM; Kumar S
    Ultrasound Obstet Gynecol; 2018 Sep; 52(3):340-346. PubMed ID: 28594099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced growth velocity across the third trimester is associated with placental insufficiency in fetuses born at a normal birthweight: a prospective cohort study.
    MacDonald TM; Hui L; Tong S; Robinson AJ; Dane KM; Middleton AL; Walker SP
    BMC Med; 2017 Aug; 15(1):164. PubMed ID: 28854913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of the Cerebro-Placental Ratio With Adverse Outcomes in Pregnancies Affected by Gestational Diabetes Mellitus.
    Ganor Paz Y; Barzilay E; Saied Idriss S; Murray-Davis B; Melamed N; Ray J; Geary M; McDonald S; Barrett J; Mawjee K; Bagheri N; Berger H
    J Ultrasound Med; 2022 Nov; 41(11):2767-2774. PubMed ID: 35174894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of operative delivery for intrapartum fetal compromise in small-for-gestational-age fetuses at term: external validation of the IRIS algorithm.
    Kalafat E; Morales-Rosello J; Scarinci E; Thilaganathan B; Khalil A
    J Matern Fetal Neonatal Med; 2020 Aug; 33(16):2775-2784. PubMed ID: 30563383
    [No Abstract]   [Full Text] [Related]  

  • 37. Role of Cerebroplacental Ratio in Predicting the Outcome of Pregnancies Complicated by Diabetes.
    Cardinali F; Panunzi C; D'Antonio F; Khalil A; Spinillo A; Arossa A; Familiari A; Pagani G; Resta S; Rizzo G
    Fetal Diagn Ther; 2024; 51(1):55-65. PubMed ID: 37926070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is cerebroplacental ratio a marker of impaired fetal growth velocity and adverse pregnancy outcome?
    Khalil A; Morales-Rosello J; Khan N; Nath M; Agarwal P; Bhide A; Papageorghiou A; Thilaganathan B
    Am J Obstet Gynecol; 2017 Jun; 216(6):606.e1-606.e10. PubMed ID: 28189607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison between Cerebroplacental Ratio and Umbilicocerebral Ratio in Predicting Adverse Perinatal Outcome in Pregnancies Complicated by Late Fetal Growth Restriction: A Multicenter, Retrospective Study.
    Di Mascio D; Herraiz I; Villalain C; Buca D; Morales-Rosello J; Loscalzo G; Sileo FG; Finarelli A; Bertucci E; Facchinetti F; Rizzo G; Brunelli R; Giancotti A; Muzii L; Maruotti GM; Carbone L; D'Amico A; Tinari S; Morelli R; Cerra C; Nappi L; Greco P; Liberati M; Galindo A; D'Antonio F
    Fetal Diagn Ther; 2021; 48(6):448-456. PubMed ID: 34130275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal change in cerebroplacental ratio in small-for-gestational-age fetuses and risk of stillbirth.
    Kalafat E; Ozturk E; Sivanathan J; Thilaganathan B; Khalil A
    Ultrasound Obstet Gynecol; 2019 Oct; 54(4):492-499. PubMed ID: 30549126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.